These ABC transporters, by utilizing energy derived from ATP hydrolysis, extrude substrates from the cytoplasm to the extracellular matrix, resulting in decreased sensitivity of cancer cells to substrate drugs. The gene discussed is ABCG2; the disease is cancer.